University of Oxford
Search
SingMalNet Logo

Research Fellow Konstantinos Kousis Presents Latest Work in Infection Biology

28 May 2026
A Photo of Andrew Duncan presenting on stage.

OptiViVax Study Presented at American Society of Tropical Medicine and Hygiene Annual Meeting 2025

09 December 2025
a close-up photo of a mosquito on human skin.

OptiViVax Launches a First-in-kind Clinical Trial on Relapsing Malaria

23 January 2025
Vaccine Cover Page

New Study Advances Research Towards Improved Vaccine Candidates for Vivax Malaria

07 May 2024
optivivax consortium group photo2

Press Release: OptiViVax, A New International Collaboration to Optimise a Vaccine for Plasmodium Vivax Malaria

13 October 2023

Contact Us

Address:
Dorothy Crowfoot Hodgkin Building
University of Oxford,
South Parks Rd
Oxford OX1 3QU
Tel:
+44 (0)1865 613200

Email:
optivivax@paediatrics.ox.ac.uk

Mandatory Links

Accessibility statement

Privacy policy

Cookies

Copyright

Follow us on Social Media
Visit our Bluesky profile

© University of Oxford 2026

 

DISCLAIMER
“OptiViVax is co-funded from the European Union Horizon Europe programme under grant agreement No. 101080744, UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant No. 10077974) and Swiss Government’s State Secretariat for Education, Research, and Innovation (SERI No. 23.00182). 
Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union, UK Research and Innovation or Swiss Government’s State Secretariat for Education, Research, and Innovation. Neither the European Union, UK Research and Innovation or Swiss Government’s State Secretariat for Education, Research, and Innovation nor the granting authority can be held responsible for them.”

eu disclaimer